Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.01), Briefing.com reports. Xenon Pharmaceuticals had a negative return on equity of 17.90% and a negative net margin of 862.06%. During the same period […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by ($0.01), Briefing.com reports. Xenon Pharmaceuticals had a negative net margin of 862.06% and a negative return on equity of 17.90%. During the same […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) posted its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.63) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.62) by ($0.01), Briefing.com reports. Xenon Pharmaceuticals had a negative net margin of 862.06% and a negative return on equity of 17.90%. During the same quarter […]
Xenon Pharmaceuticals (NASDAQ:XENE – Get Rating) announced its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by ($0.01), Briefing.com reports. Xenon Pharmaceuticals had a negative net margin of 862.06% and a negative return on equity of 17.90%. During the same […]
Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) hit a new 52-week high during trading on Thursday . The stock traded as high as $41.60 and last traded at $41.36, with a volume of 443718 shares changing hands. The stock had previously closed at $40.78. Wall Street Analyst Weigh In Several equities analysts have […]